After a slow 2020, biotech dealmaking in 2021 is off to a good start. However, the industry is experiencing profound changes. By Michael Megarit 5 Trends That Will Define Biotech Dealmaking in 2021-22 2020 was a particular year. In March, Coronavirus lockdowns halted global economic activity. However, pharmaceutical firms showed great [...]